Hartford Funds Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Hartford Funds Management's PFE Position: Q2 2026 in Review
Hartford Funds Management reduced its Pfizer (PFE) stake by 3.1% in Q2 2026, selling an estimated $31K and leaving 37,508 shares worth $903K. The position accounts for 0.07% of the portfolio, ranked #79.
Hartford Funds Management first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.09M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Hartford Funds Management held 37,508 shares of Pfizer worth $903K as of Q2 2026.
- Hartford Funds Management sold 1,186 Pfizer shares in Q2 2026, an estimated $31K.
- Pfizer made up 0.07% of Hartford Funds Management's portfolio in Q2 2026, its #79 holding.
- Hartford Funds Management first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
- Hartford Funds Management's Pfizer position peaked at $1.09M in Q1 2026.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Hartford Funds Management's 13F filing for Q2 2026, filed 6 Aug 2026.